Isabel Aznarez

52 year

Consumer Services

Commercial Services

Health Technology

Profile

Isabel Aznarez is the founder of Stoke Therapeutics, Inc. which was founded in 2014.
She holds the title of Senior Vice President-Discovery Research at Stoke Therapeutics, Inc. Dr. Aznarez's current job is as a Director at Oligonucleotide Therapeutics Society, Inc. since 2019.
Dr. Aznarez obtained a doctorate degree from the University of Toronto in 2006 and also has an undergraduate degree from Universidad De La Republica Uruguay.

Isabel Aznarez active positions

Companies	Position	Start
STOKE THERAPEUTICS, INC.	Founder	31/05/2014
Oligonucleotide Therapeutics Society, Inc. Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators.	Director/Board Member	31/12/2018

All active positions of Isabel Aznarez

Training of Isabel Aznarez

University of Toronto	Doctorate Degree
Universidad De La Republica Uruguay	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Isabel Aznarez's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
STOKE THERAPEUTICS, INC.	Health Technology

Private companies	1
Oligonucleotide Therapeutics Society, Inc. Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators.	Commercial Services